Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.

@article{Blanco2011ImpactOA,
  title={Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.},
  author={No{\'e}mie Boillat Blanco and M Virginia Pascual and Jean-Pierre Venetz and Ghaleb Nseir and Pascal R. A. Meylan and Oriol Manuel},
  journal={Transplantation},
  year={2011},
  volume={91 2},
  pages={251-5}
}
BACKGROUND We assessed the impact of a preemptive strategy after discontinuation of antiviral prophylaxis in the prevention of late-onset cytomegalovirus (CMV) disease in a cohort of kidney transplant recipients. METHODS Patients undergoing kidney transplantation at the University Hospital of Lausanne (CHUV) between November 2003 and November 2007 were included if they were donor or recipient (D/R) seropositive for CMV. All patients received 3 months of prophylaxis with valganciclovir… CONTINUE READING